S' strong prospects, driven by an expanding AI-powered portfolio, as well as a solid partner base, are noteworthy. However, a stretched valuation is a concern.
SOCs are seeing false positive rates drop 70%, while shaving 40+ hrs a week of manual triage thanks to the rapid advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback